|
|
||||||||
Short Communication |
1 Transplant Division, Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
2 Department of Microbiology and Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
3 Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA
Correspondence
Michael Abecassis
mabecass{at}nmh.org
| ABSTRACT |
|---|
|
|
|---|
| MAIN TEXT |
|---|
|
|
|---|
The CMV ie genes are the first set of genes expressed during productive infection and encode transcriptional transactivator proteins whose expression is required for progression to later stages of virus replication (Mocarski & Courcell, 2001
). In spleens, of which approximately 90 % were negative for ie gene expression prior to explant, induction of ie gene expression generally did not occur until 910 days in culture (Fig. 1
). Release of infectious virus in the medium was rarely detectable until approximately 12 days after explant (Fig. 2
). CMV is a slowly replicating virus and plaques are detectable 35 days after infection of permissive fibroblasts in vitro. These studies suggest that induction of ie gene expression is the rate-determining step in reactivation and that, once induction of ie gene expression has occurred, reactivation recapitulates productive infection in vitro.
|
|
m157 strain of MCMV (Bubic et al., 2004
m157 were explanted and monitored for the production of virus. No difference in the ability of MCMV to reactivate from explants of WT or TNFR-deficient mice was observed (data not shown).
Recent studies with human CMV-infected cells indicate that changes in histone modifications are associated with reactivation from latency (Meier, 2001
; Reeves et al., 2005
). Activation of genes silenced through epigenetic mechanisms has been achieved by incubation with 5-aza-2'-deoxycytidine (5-aza-dC), an inhibitor of de novo DNA methylation, and/or with the histone deacetylase inhibitor trichostatin A (TSA) (Chen et al., 2001
; El Kharroubi et al., 2001
; Grassi et al., 2003
; Magdinier & Wolffe, 2001
; Masucci et al., 1989
). We therefore investigated the effect of adding TSA, 5-aza-dC or both to cultures of spleen explants from latently infected mice (Fig. 2a
, lanes E). In this and additional experiments, induction of ie gene expression was observed in 1 of 21 explants cultured for 3 days without addition of drug and 1 of 6 explants cultured with TSA alone (
2 analysis, not significant). Incubation for 3 days in the presence of 5-aza-dC alone or the combination of 5-aza-dC and TSA induced ie gene expression in 2 of 6 and 12 of 15 of the cultures, respectively. The effect of 5-aza-dC alone is statistically significant (
2 analysis, P<0.05), and the effect of TSA and 5-aza-dC together is greater than that of 5-aza-dC alone (
2 analysis, P<0.05). These studies demonstrate that 5-aza-dC can induce ie gene expression and that 5-aza-dC and TSA act synergistically to enhance transcriptional reactivation of ie gene expression.
The kinetics of virus production in medium from explants of nine mice treated with or without 5-aza-dC and TSA was analysed at 7, 10 and 12 days post-explant (Fig. 2c
). Consistent with the observation that ie gene expression is not detectable until 910 days post-explant (Fig. 1
), virus was rarely detectable prior to 10 days in untreated cultures, but increased exponentially starting at 12 days post-explant. Treatment of explants with 5-aza-dC and TSA caused a statistically significant increase in virus production over untreated controls at 7 and 10 days post-explant (t-test, P<0.05). Thus, treatment of explants with 5-aza-dC and TSA results in more rapid reactivation of both ie gene expression and virus production.
Analysis of the sequence of CMV DNAs shows a marked suppression in the frequency of CpG dinucleotides in the ie region, suggesting the presence of DNA methylation and its associated transcriptional silencing (Herman & Baylin, 2003
; Honess et al., 1989
). In addition, the observation that treatment of explants with 5-aza-dC was sufficient to induce transcriptional reactivation of ie gene expression suggested that latency might be controlled in part through DNA methylation-induced silencing of ie gene expression. We therefore looked directly for evidence of methylation of ie-1 DNA. The greatest deficit in the ratio of observed to expected CpGs in MCMV DNA occurs within exon 4 of the ie-1 gene and in the enhancer region (Fig. 3a, b
). Methylation of coding regions does not interfere with transcription (Jones, 1999
). We therefore used the bisulfite modification method (Clark et al., 1994
) to analyse methylation of CpG dinucleotides in the promoter/enhancer region spanning nt 251 to +42 relative to the ie-1 transcription start site in DNAs from organs of nine latently infected mice (Fig. 3b
). Bisulfite treatment converts unmethylated C to U, which are converted to T after PCR amplification. Methylated Cs are protected from conversion. Bisulfite-modified DNAs were amplified by strand-specific nested PCR (Herman et al., 1996
), cloned and sequenced. Methylated CpGs remain as CpG, while unmethylated CpGs are converted to TpG. Because incomplete conversion of Cs will result in a false positive, conversion of Cs in non-CpGs is used as an internal control for completeness of the reaction. Only clones in which >95 % of the Cs in non-CpGs are converted were analysed. RNA was isolated from the same organs and analysed for expression of ie transcripts to ensure that the mice were negative for ie gene expression. In many cases, MCMV DNA could not be amplified after bisulfite treatment because the DNA copy number is very low in MCMV-latent mice, and bisulfite treatment results in substantial degradation of the DNA (Raizis et al., 1995
). However, we were able to analyse 312 clones of 10 independent PCR from DNA isolated from various organs of nine mice. One hundred per cent of the C residues in CpG dinucleotides were converted to T residues in clones in which more than 95 % of the Cs in non-CpGs were converted to T. As positive controls, we analysed four of these DNAs for methylation of the Ant4 promoter, which is highly methylated in adult mouse organs (Rodic et al., 2005
). As expected, CpGs in the Ant4 promoter were protected from conversion in bisulfite-modified DNA. These results indicate that CpG dinucleotides in the ie promoter/enhancer region are not methylated in latently infected mice.
|
In addition, we investigated methylation of the intron between exons 1 and 2 and in the region encoding exons 2 and 3 by methylation-sensitive restriction enzyme analysis. No methylation of CpGs in the MluI, SacII or HhaI sites in intron 1 or the BsaAI, HincII or XhoI sites in exons 2 and 3 was observed (Fig. 3d, e
; BsaA1 data not shown). Although this method allows analysis of a very limited set of CpG dinucleotides within the gene, our results suggest that methylation of other regions of the ie-1 gene is unlikely.
In this study, we find that transcriptional reactivation of ie gene expression in explants is followed by reactivation of infectious virus with kinetics similar to that observed with infection in vitro. These results suggest that induction of ie gene expression is the rate-determining step in reactivation of the virus. In addition, we find that induction of ie gene expression in explants occurs much more rapidly in the presence of 5-aza-dC and TSA. Although the CpG deficit in the enhancer region and the observation that 5-aza-dC alone can induce ie gene expression would seem to suggest a role for DNA methylation in transcriptional silencing, the promoter/enhancer appears to be unmethylated. The lack of CpGs in the enhancer may be due to a selective pressure in favour of multiple AP-1- and NF-
B-binding sites, which lack this sequence (Fig. 3c
). The effect of 5-aza-dC may be due to DNA methylation-independent effects on histone acetylation (Nguyen et al., 2002
; Takebayashi et al., 2001
). While we cannot exclude the possibility that the effects of 5-aza-dC and TSA in this system are unrelated to epigenetic control of ie gene expression, our studies are consistent with previous studies suggesting that latency is achieved through an active mechanism of transcriptional silencing involving histone modifications (Reeves et al., 2005
).
| ACKNOWLEDGEMENTS |
|---|
m157 virus. This work is supported by USPHS grant R01 AI42898 to M. A. | REFERENCES |
|---|
|
|
|---|
Chen, J., Ueda, K., Sakakibara, S., Okuno, T., Parravicini, C., Corbellino, M. & Yamanishi, K. (2001). Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci U S A 98, 41194124.
Clark, S. J., Harrison, J., Paul, C. L. & Frommer, M. (1994). High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22, 29902997.
Dorsch-Hasler, K., Keil, G. M., Weber, F., Jasin, M., Schaffner, W. & Koszinowski, U. H. (1985). A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate-early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A 82, 83258329.
El Kharroubi, A., Piras, G. & Stewart, C. L. (2001). DNA demethylation reactivates a subset of imprinted genes in uniparental mouse embryonic fibroblasts. J Biol Chem 276, 86748680.
Grassi, G., Maccaroni, P., Meyer, R., Kaiser, H., D'Ambrosio, E., Pascale, E., Grassi, M., Kuhn, A., Di Nardo, P. & other authors (2003). Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Carcinogenesis 24, 16251635.
Herman, J. G. & Baylin, S. B. (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349, 20422054.
Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. & Baylin, S. B. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93, 98219826.
Honess, R. W., Gompels, U. A., Barrell, B. G., Craxton, M., Cameron, K. R., Staden, R., Chang, Y. N. & Hayward, G. S. (1989). Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J Gen Virol 70, 837855.
Hummel, M., Zhang, Z., Yan, S., DePlaen, I., Golia, P., Varghese, T., Thomas, G. & Abecassis, M. I. (2001). Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol 75, 48144822.
Jones, P. A. (1999). The DNA methylation paradox. Trends Genet 15, 3437.[CrossRef][Medline]
Jordan, M. C. & Mar, V. L. (1982). Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus. J Clin Invest 70, 762768.[Medline]
Koffron, A. J., Hummel, M., Patterson, B. K., Yan, S., Kaufman, D. B., Fryer, J. P., Stuart, F. P. & Abecassis, M. I. (1998). Cellular localization of latent murine cytomegalovirus. J Virol 72, 95103.
Kurz, S. K., Rapp, M., Steffens, H. P., Grzimek, N. K., Schmalz, S. & Reddehase, M. J. (1999). Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73, 482494.
Magdinier, F. & Wolffe, A. P. (2001). Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci U S A 98, 49904995.
Masucci, M. G., Contreras-Salazar, B., Ragnar, E., Falk, K., Minarovits, J., Ernberg, I. & Klein, G. (1989). 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. J Virol 63, 31353141.
Meier, J. L. (2001). Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J Virol 75, 15811593.
Mocarski, E. S. & Courcell, C. T. (2001). Cytomegaloviruses and their replication. In Fields Virology, 4th edn, pp. 26292673. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J. C., Liang, G. & Jones, P. A. (2002). Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res 62, 64566461.
Raizis, A. M., Schmitt, F. & Jost, J. P. (1995). A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal Biochem 226, 161166.[CrossRef][Medline]
Rawlinson, W. D., Farrell, H. E. & Barrell, B. G. (1996). Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70, 88338849.[Abstract]
Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G. & Sinclair, J. H. (2005). Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102, 41404145.
Rodic, N., Oka, M., Hamazaki, T., Murawski, M. R., Jorgensen, M., Maatouk, D. M., Resnick, J. L., Li, E. & Terada, N. (2005). DNA methylation is required for silencing of Ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells 23, 13141323.
Takebayashi, S., Nakao, M., Fujita, N., Sado, T., Tanaka, M., Taguchi, H. & Okumura, K. (2001). 5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation. Biochem Biophys Res Commun 288, 921926.[CrossRef][Medline]
Received 8 November 2006;
accepted 29 November 2006.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |